Bausch Health Companies (BHC) Net Equity Issued and Repurchased (2013 - 2015)

Bausch Health Companies (BHC) reported Net Equity Issued and Repurchased of -$700000.0 for Q4 2015, down 100.05% sequentially from $1.4 billion in Q1 2015.

Bausch Health Companies (BHC) Net Equity Issued and Repurchased (2013 - 2015) Analysis & Trends

Bausch Health Companies (BHC) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$700000.0 in Q4 2015.

  • For the quarter ending Q4 2015, Net Equity Issued and Repurchased changed N/A year-over-year to -$700000.0; the trailing twelve-month figure through Sep 2016 stood at -$700000.0 (down 100.05% YoY), and the FY2015 full-year result was $1.4 billion, changed N/A from the prior year.
  • Net Equity Issued and Repurchased retreated to -$700000.0 in Q4 2015, from $1.4 billion in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $2.3 billion in Q2 2013 to a low of -$1.3 million in Q3 2013.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 -700,000.00
Dec 31, 2015 -700,000.00
Mar 31, 2015 1.43 Bn
Mar 31, 2015 1.43 Bn
Dec 31, 2013 37.50 Mn
Dec 31, 2013 37.50 Mn
Sep 30, 2013 -1.30 Mn
Sep 30, 2013 -1.30 Mn
Jun 30, 2013 2.27 Bn
Jun 30, 2013 2.27 Bn